CN105362785A - Medicine composition for treating primary hypertension and preparation method thereof - Google Patents
Medicine composition for treating primary hypertension and preparation method thereof Download PDFInfo
- Publication number
- CN105362785A CN105362785A CN201510956534.6A CN201510956534A CN105362785A CN 105362785 A CN105362785 A CN 105362785A CN 201510956534 A CN201510956534 A CN 201510956534A CN 105362785 A CN105362785 A CN 105362785A
- Authority
- CN
- China
- Prior art keywords
- parts
- ampelopsis grossedentata
- medicine composition
- chinese medicine
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 86
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 208000007530 Essential hypertension Diseases 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 229940079593 drug Drugs 0.000 title abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 54
- 239000000284 extract Substances 0.000 claims abstract description 51
- 241001243004 Sceptridium japonicum Species 0.000 claims abstract description 16
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 10
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 10
- 238000005516 engineering process Methods 0.000 claims abstract description 7
- 241001018563 Nekemias grossedentata Species 0.000 claims description 71
- 239000000843 powder Substances 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 47
- 210000000582 semen Anatomy 0.000 claims description 35
- 240000004307 Citrus medica Species 0.000 claims description 32
- 239000000243 solution Substances 0.000 claims description 31
- 239000007864 aqueous solution Substances 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 27
- 238000001035 drying Methods 0.000 claims description 21
- 239000012567 medical material Substances 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 241000219925 Oenothera Species 0.000 claims description 18
- 235000004496 Oenothera biennis Nutrition 0.000 claims description 18
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 18
- 229940088598 enzyme Drugs 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 18
- 229930003944 flavone Natural products 0.000 claims description 18
- 150000002212 flavone derivatives Chemical class 0.000 claims description 18
- 235000011949 flavones Nutrition 0.000 claims description 18
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 18
- 241000219198 Brassica Species 0.000 claims description 15
- 235000003351 Brassica cretica Nutrition 0.000 claims description 15
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 15
- 240000005827 Phyllostachys nigra Species 0.000 claims description 15
- 235000010717 Phyllostachys nigra Nutrition 0.000 claims description 15
- 241000219780 Pueraria Species 0.000 claims description 15
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 15
- 239000009609 fructus phyllanthi Substances 0.000 claims description 15
- 101150087532 mitF gene Proteins 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 235000010460 mustard Nutrition 0.000 claims description 15
- 238000009835 boiling Methods 0.000 claims description 14
- 238000001179 sorption measurement Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 239000010883 coal ash Substances 0.000 claims description 11
- 238000010304 firing Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 108010059892 Cellulase Proteins 0.000 claims description 9
- 102000012286 Chitinases Human genes 0.000 claims description 9
- 108010022172 Chitinases Proteins 0.000 claims description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
- 108090000526 Papain Proteins 0.000 claims description 9
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 9
- 239000004365 Protease Substances 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000006286 aqueous extract Substances 0.000 claims description 9
- 229940106157 cellulase Drugs 0.000 claims description 9
- 238000004587 chromatography analysis Methods 0.000 claims description 9
- 239000013078 crystal Substances 0.000 claims description 9
- 238000002425 crystallisation Methods 0.000 claims description 9
- 230000008025 crystallization Effects 0.000 claims description 9
- 230000018044 dehydration Effects 0.000 claims description 9
- 238000006297 dehydration reaction Methods 0.000 claims description 9
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000008101 lactose Substances 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 9
- 238000000643 oven drying Methods 0.000 claims description 9
- 229940055729 papain Drugs 0.000 claims description 9
- 235000019834 papain Nutrition 0.000 claims description 9
- 230000005855 radiation Effects 0.000 claims description 9
- 239000011347 resin Substances 0.000 claims description 9
- 229920005989 resin Polymers 0.000 claims description 9
- 239000000741 silica gel Substances 0.000 claims description 9
- 229910002027 silica gel Inorganic materials 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 230000001476 alcoholic effect Effects 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000013049 sediment Substances 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 238000001354 calcination Methods 0.000 claims description 6
- 239000004927 clay Substances 0.000 claims description 6
- 230000036772 blood pressure Effects 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 22
- 230000006870 function Effects 0.000 abstract description 15
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 210000001124 body fluid Anatomy 0.000 abstract description 11
- 239000010839 body fluid Substances 0.000 abstract description 11
- 230000035922 thirst Effects 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 8
- 230000004438 eyesight Effects 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract 2
- 231100000419 toxicity Toxicity 0.000 abstract 2
- 241000772879 Artocarpus hypargyreus Species 0.000 abstract 1
- 244000178993 Brassica juncea Species 0.000 abstract 1
- 235000008537 Brassica juncea var. integrifolia Nutrition 0.000 abstract 1
- 240000006248 Broussonetia kazinoki Species 0.000 abstract 1
- 244000119298 Emblica officinalis Species 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 240000007227 Oberonia iridifolia Species 0.000 abstract 1
- 240000002014 Phyllostachys nigra var. henonis Species 0.000 abstract 1
- 241001601830 Piptanthus concolor Species 0.000 abstract 1
- 241001085873 Pternopetalum nudicaule Species 0.000 abstract 1
- 241001412178 Rubus pluribracteatus Species 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 240000003294 Thysanolaena latifolia Species 0.000 abstract 1
- 244000285482 Vitis flexuosa Species 0.000 abstract 1
- 235000000481 Vitis flexuosa Nutrition 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 229940045761 evening primrose extract Drugs 0.000 abstract 1
- 230000000366 juvenile effect Effects 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 230000003340 mental effect Effects 0.000 abstract 1
- 239000000779 smoke Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 210000003813 thumb Anatomy 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 230000015271 coagulation Effects 0.000 description 12
- 238000005345 coagulation Methods 0.000 description 12
- 238000001727 in vivo Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 7
- 208000005946 Xerostomia Diseases 0.000 description 7
- 206010061428 decreased appetite Diseases 0.000 description 7
- 206010013781 dry mouth Diseases 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- 102100027378 Prothrombin Human genes 0.000 description 6
- 108010094028 Prothrombin Proteins 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 208000022531 anorexia Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000002785 anti-thrombosis Effects 0.000 description 6
- 239000003146 anticoagulant agent Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 229910052802 copper Inorganic materials 0.000 description 6
- 239000010949 copper Substances 0.000 description 6
- 235000004626 essential fatty acids Nutrition 0.000 description 6
- 206010016766 flatulence Diseases 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 230000001631 hypertensive effect Effects 0.000 description 6
- 230000002757 inflammatory effect Effects 0.000 description 6
- 150000002617 leukotrienes Chemical class 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 208000010125 myocardial infarction Diseases 0.000 description 6
- 150000003180 prostaglandins Chemical class 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 229940039716 prothrombin Drugs 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 230000000977 initiatory effect Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- -1 oxygen ion Chemical class 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 235000010855 food raising agent Nutrition 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 229940097420 Diuretic Drugs 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 229940127291 Calcium channel antagonist Drugs 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 229940125364 angiotensin receptor blocker Drugs 0.000 description 2
- 239000002876 beta blocker Substances 0.000 description 2
- 229940097320 beta blocking agent Drugs 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000000480 calcium channel blocker Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine composition for treating primary hypertension and a preparation method thereof. The medicine composition is mainly prepared from vitis flexuosa thumb., pternopetalum nudicaule(de Boiss.) hand.-mazz, botrychium japonicum, a rubus pluribracteatus root, thysanolaena maxima, brassica integrifolia, a paper mulberry root, an artocarpus hypargyreus root, oberonia iridifolia Lindl, piptanthus concolor craib, henon bamboo juvenile leaves, phyllanthus emblica, evening primrose extract, lemon extract and moyeam tea extract. Based on the traditional Chinese medicine theory, the Medicine composition is applied according to symptoms, the formula is precise, reasonable compatibility is achieved, and the Medicine composition has the functions of removing heat to cool blood, encouraging production of body fluid to extinguish thirst, removing toxicity for detumescence, removing liver-fire for improving eyesight, stopping bleeding and reducing blood pressure, can further effectively remove toxicity and relieve mental stress, promotes a normal organism diet, clears away smoke and dispels the effects of alcohol, and is remarkable in treatment effect, mild in medicinal effect and free of side effects. The preparation technology of the Medicine composition for treating primary hypertension is simple, the production cost is low, and good medical value is achieved.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of essential hypertension and preparation method thereof.
Background technology
Based on current medical development level and detection methods, can find that the definite cause of disease causing blood pressure to raise is referred to as secondary hypertension, otherwise, the definite cause of disease causing blood pressure to raise can not be found, be then called essential hypertension.In Hypertensive Population, majority is essential hypertension, current medical statistics essential hypertension accounts for 90% ~ 95% of Hypertensive Population, within 2005, American Society of Hypertension proposes, essential hypertension is a cardiovascular syndrome being in continuous state of progress caused by many causes of disease, can cause the change of heart and vascular function and structure.Think that essential hypertension is that some congenital hereditary gene a kind of and many pathogenic supercharging factors and physiological reduce pressure factor interaction and the multi-factor disease caused at present, these factors mainly comprise: the low potassium meals of hereditary, high sodium, Overweight and obesity, excessive consumption of alcohol, long-term spiritual hypertonicity etc., the life style of therefore keeping fit contributes to preventing and delay hypertensive generation.Sodium salt can significantly raising blood pressure and hypertensive onset risk, and potassium salt then can resist the effect of sodium salt raising blood pressure; Overweight and obesity is one of major reason causing blood pressure to raise, and take abdominal fat accumulation as the risk that the central obesity of typical characteristic also can increase the cardiovascular such as hypertension and metabolic disease further, the suitable body weight reducing rising, reduces body fat content, can significantly reduce blood pressure; Smoking can cause blood vessel endothelium to damage, and significantly increases the risk that atherosclerosis occurs hyperpietic; Long-term heavy drinking can cause blood pressure to raise, and restriction drinking amount then significantly can reduce hypertension; Regular physical training then can produce important therapeutical effect, can reduce blood pressure, improve carbohydrate metabolism etc.; Psychology or stress cause psychological stress, i.e. the reaction made psychology and the stimulation of physiologic factor in environment of human body.
Treatment essential hypertension also start with from many aspects come comprehensive adjustment human body balance, blood pressure is made to return to normal condition, conventional antihypertensive drugs comprises calcium channel blocker, angiotensin converting enzyme inhibitor, angiotensin receptor blocker, diuretic and beta-blocker five class, and the fixed mixing ratio compound preparation be made up of said medicine.In addition, alpha-blocking agent or other kind of hypotensor also can be applicable to some Hypertensive Population sometimes.Calcium channel blocker, ACEI, ARB, diuretic and beta-blocker and low dosage immobilised compound preparation thereof, all can be used as initial medication or the long term maintenance medication of Treatment of Hypertension, single medicine or therapeutic alliance.But more than treatment also just controls blood pressure targetedly, the object fundamentally regulating human body function to reduce blood pressure can not be reached.
Summary of the invention
For making up the deficiencies in the prior art, the invention provides a kind of good effect, instant effect, having no side effect, the Chinese medicine composition for the treatment of essential hypertension easy to use.
Another object of the present invention is to provide a kind of preparation method for the treatment of the Chinese medicine composition of essential hypertension.
For achieving the above object, technical scheme of the present invention is: a kind of Chinese medicine composition for the treatment of essential hypertension, component meter by weight, mainly be made up of following raw material: Pueraria lobota Bud root 60 ~ 90 parts, medicine root of Herba Apii graveolentis 55 ~ 80 parts, Botrychium japonicum (Prantl) underw 52 ~ 78 parts, Radix Rubi Setchuenensis 42 ~ 65 parts, Herba Thysanolaenae maximae 40 ~ 58 parts, bitter 38 ~ 56 parts, mustard, Radix broussonetiae 38 ~ 55 parts, Bai Guimu root 35 ~ 52 parts, Herba Oberoniae iridifoliae 36 ~ 48 parts, Semen piptanthi concoloris 34 ~ 46 parts, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle 30 ~ 45 parts, Fructus Phyllanthi 30 ~ 43 parts, Radix Oenotherae erythrosepalae extract 4.2 ~ 5.6 parts, citron extract 3.8 ~ 5.4 parts, Ampelopsis grossedentata extrat 2.8 ~ 4.6 parts.
Further, described a kind of Chinese medicine composition for the treatment of essential hypertension, component meter by weight, is mainly made up of following raw material: Pueraria lobota Bud root 75 parts, medicine root of Herba Apii graveolentis 68 parts, Botrychium japonicum (Prantl) underw 65 parts, Radix Rubi Setchuenensis 54 parts, Herba Thysanolaenae maximae 49 parts, 47 parts, bitter mustard, Radix broussonetiae 46 parts, Bai Guimu root 44 parts, Herba Oberoniae iridifoliae 42 parts, Semen piptanthi concoloris 40 parts, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle 38 parts, Fructus Phyllanthi 37 parts, Radix Oenotherae erythrosepalae extract 4.9 parts, citron extract 4.6 parts, Ampelopsis grossedentata extrat 3.7 parts.
Further, described Radix Oenotherae erythrosepalae extract is Radix Oenotherae erythrosepalae oil, its extracting method is: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 100 ~ 120 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, enzymolysis 2 ~ 5h under the condition of vacuum-0.03 ~-0.05MPa and temperature 50 ~ 60 DEG C, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 80 ~ 90 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained.Contain in Radix Oenotherae erythrosepalae oil: r-linoleic acid, magnesium, zinc, the effective ingredient such as copper, injection Vitamin B_6, B6, B5, be the extremely polynary undersaturated essential fatty acid of one, the endogenous factor of inflammatory that Oleum Arachidis hypogaeae semen tetraenoic acid produces in vivo can be replaced in the process of metabolism in vivo, as prostaglandin, leukotrienes and the Prothrombin causing Coagulation test, except anti-inflammatory effect, Radix Oenotherae erythrosepalae oil also has the effect reducing Coagulation test, antithrombotic.
Further, described mixed enzyme to be fully uniformly mixed according to the weight ratio of 4:1:2 by chitinase, cellulase, papain to obtain, it carries out enzymolysis to organic substances such as cellulose, starch, protein in Radix Oenotherae erythrosepalae and the mixed solution of water respectively, thus isolates the active substance containing Radix Oenotherae erythrosepalae oil fast.
Further, described citron extract preparation method is: cleaned by lemon fruit, is ground into 20 ~ 40 orders with pulverizer, carries out supersound extraction with ethanol, solid-liquid ratio is 1:(2 ~ 6), the mass concentration of ethanol is 60 ~ 80%, and ultrasonic power is 30 ~ 40KHz, and temperature is 55 DEG C, extraction time is 30 minutes, be separated with macroporous adsorption resin chromatography, dry, the brown color fine powder obtained is citron extract again.Citron extract has and promotes the production of body fluid, and quenches the thirst, drives away summer heat, antiabortive, pharyngalgia xerostomia, gastral cavilty flatulence, hypertension, myocardial infarction, effect of anorexia.
Further, described Ampelopsis grossedentata extrat preparation method is: by Ampelopsis grossedentata crushed after being dried, cross 20 ~ 30 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is 3, filter after 85 DEG C of heating 30min leave standstill, obtain Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, be cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtain Ampelopsis grossedentata extrat.
Treat a preparation method for the Chinese medicine composition of essential hypertension, comprise the following steps:
Step one: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 100 ~ 120 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, described mixed enzyme is by chitinase, cellulase, papain is fully uniformly mixed according to the weight ratio of 4:1:2 and obtains, it is respectively to cellulose in Radix Oenotherae erythrosepalae and the mixed solution of water, starch, the organic substances such as protein carry out enzymolysis, thus the active substance isolated fast containing Radix Oenotherae erythrosepalae oil, enzymolysis 2 ~ 5h under the condition of vacuum-0.03 ~-0.05MPa and temperature 50 ~ 60 DEG C, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 80 ~ 90 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained, contain in Radix Oenotherae erythrosepalae oil: r-linoleic acid, magnesium, zinc, copper, vitamin C, E, B6, the effective ingredient such as B5, it is the extremely polynary undersaturated essential fatty acid of one, the endogenous factor of inflammatory that Oleum Arachidis hypogaeae semen tetraenoic acid produces in vivo can be replaced in the process of metabolism in vivo, as prostaglandin, the Prothrombin of leukotrienes and initiation Coagulation test, except anti-inflammatory effect, Radix Oenotherae erythrosepalae oil also has reduction Coagulation test, the effect of antithrombotic,
Step 2: lemon fruit is cleaned, be ground into 20 ~ 40 orders with pulverizer, carry out supersound extraction with ethanol, solid-liquid ratio is 1:(2 ~ 6), the mass concentration of ethanol is 60 ~ 80%, ultrasonic power is 30 ~ 40KHz, and temperature is 55 DEG C, and extraction time is 30 minutes, be separated with macroporous adsorption resin chromatography again, drying, the brown color fine powder obtained is citron extract, and citron extract has and promotes the production of body fluid, quench the thirst, drive away summer heat, antiabortive, pharyngalgia xerostomia, gastral cavilty flatulence, hypertension, myocardial infarction, effect of anorexia;
Step 3: by Ampelopsis grossedentata crushed after being dried, cross 20 ~ 30 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is filter after 3,85 DEG C of heating 30min leave standstill, and obtains Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, is cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtains Ampelopsis grossedentata extrat;
Step 4: take Pueraria lobota Bud root by described components by weight percent, medicine root of Herba Apii graveolentis, Botrychium japonicum (Prantl) underw, Radix Rubi Setchuenensis, Radix broussonetiae, Bai Guimu root, Fructus Phyllanthi, all medical materials are cut into the thin slice of 2mm, be placed in oven for drying, baking oven set temperature 60 DEG C, make Chinese medicine tablet moisture lower than 5%, take the Semen piptanthi concoloris seed of described components by weight percent, crushed after being dried, cross 50 mesh sieves, obtain Semen piptanthi concoloris coarse powder, by Chinese medicine tablet and the mixing of Semen piptanthi concoloris coarse powder, add the pure water of 8 ~ 10 times amount of mixing medical material gross weight, soak 8 ~ 12h, use special marmite, fine coal ash quantity after described special marmite refers to the calcining added in clay is 1.2 times that common marmite is fired, firing temperature is higher than common marmite 100 DEG C, the raising of fine coal ash quantity can increase the activated carbon constituents in marmite, thus a large amount of negative oxygen ion can be formed make to have strong physical absorption and chemical adsorption capacity, therefore can except the heavy metal ion in anhydrating, stink, rust etc., and effectively can stop the loss of effective ingredient in medical material, improving firing temperature can make the heat-resisting quantity of marmite improve, can more be uniformly dissolved from making medicinal ingredient, intense fire heated and boiled, slow fire boiling is extracted, decoct 2-3 hour, again add the pure water of 6 ~ 8 times amount, intense fire heated and boiled, slow fire boiling is extracted, decoct 1 ~ 2 hour, merge the extracting solution of twice,
Step 5: take fresh Herba Thysanolaenae maximae by described components by weight percent, bitter mustard, Herba Oberoniae iridifoliae, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle smash to pieces, and the mass concentration adding 5 times amount is 75% alcoholic solution, blender is used to stir 30min, the supernatant is extracted after leaving standstill 12h, carry out 85 ~ 95 DEG C of microwave sterilizating, sterilization time 90 ~ 120s, reclaims the ethanol in filtrate and concentrates, obtained mixture extractum;
Step 6: the mixture extractum mix homogeneously that extracting solution step 4 obtained and step 5 obtain, 3h is left standstill after stirring, then centrifuge 5000 ~ 6000r/min centrifugal sediment is used, filter, add Radix Oenotherae erythrosepalae extract, citron extract, the Ampelopsis grossedentata extrat of described components by weight percent more respectively, the Chinese medicine composition of the essential hypertension that namely obtains medical treatment.
Further, the preparation method that a kind of Chinese medicine composition for the treatment of essential hypertension makes capsule comprises the following steps:
Step one: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 100 ~ 120 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, described mixed enzyme is by chitinase, cellulase, papain is fully uniformly mixed according to the weight ratio of 4:1:2 and obtains, it is respectively to cellulose in Radix Oenotherae erythrosepalae and the mixed solution of water, starch, the organic substances such as protein carry out enzymolysis, thus isolate active substance containing Radix Oenotherae erythrosepalae oil enzymolysis 2 ~ 5h under the condition of vacuum-0.03 ~-0.05MPa and temperature 50 ~ 60 DEG C fast, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 80 ~ 90 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained, contain in Radix Oenotherae erythrosepalae oil: r-linoleic acid, magnesium, zinc, copper, vitamin C, E, B6, the effective ingredient such as B5, it is the extremely polynary undersaturated essential fatty acid of one, the endogenous factor of inflammatory that Oleum Arachidis hypogaeae semen tetraenoic acid produces in vivo can be replaced in the process of metabolism in vivo, as prostaglandin, the Prothrombin of leukotrienes and initiation Coagulation test, except anti-inflammatory effect, Radix Oenotherae erythrosepalae oil also has reduction Coagulation test, the effect of antithrombotic,
Step 2: lemon fruit is cleaned, be ground into 20 ~ 40 orders with pulverizer, carry out supersound extraction with ethanol, solid-liquid ratio is 1:(2 ~ 6), the mass concentration of ethanol is 60 ~ 80%, ultrasonic power is 30 ~ 40KHz, and temperature is 55 DEG C, and extraction time is 30 minutes, be separated with macroporous adsorption resin chromatography again, drying, the brown color fine powder obtained is citron extract, and citron extract has and promotes the production of body fluid, quench the thirst, drive away summer heat, antiabortive, pharyngalgia xerostomia, gastral cavilty flatulence, hypertension, myocardial infarction, effect of anorexia;
Step 3: by Ampelopsis grossedentata crushed after being dried, cross 20 ~ 30 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is filter after 3,85 DEG C of heating 30min leave standstill, and obtains Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, is cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtains Ampelopsis grossedentata extrat;
Step 4: take Pueraria lobota Bud root by described components by weight percent, medicine root of Herba Apii graveolentis, Botrychium japonicum (Prantl) underw, Radix Rubi Setchuenensis, Radix broussonetiae, Bai Guimu root, Fructus Phyllanthi, all medical materials are cut into the thin slice of 2mm, be placed in oven for drying, baking oven set temperature 60 DEG C, make Chinese medicine tablet moisture lower than 5%, take the Semen piptanthi concoloris seed of described components by weight percent, crushed after being dried, cross 50 mesh sieves, obtain Semen piptanthi concoloris coarse powder, by Chinese medicine tablet and the mixing of Semen piptanthi concoloris coarse powder, add the pure water of 8 ~ 10 times amount of mixing medical material gross weight, soak 8 ~ 12h, use special marmite, fine coal ash quantity after described special marmite refers to the calcining added in clay is 1.2 times that common marmite is fired, firing temperature is higher than common marmite 100 DEG C, the raising of fine coal ash quantity can increase the activated carbon constituents in marmite, thus a large amount of negative oxygen ion can be formed make to have strong physical absorption and chemical adsorption capacity, therefore can except the heavy metal ion in anhydrating, stink, rust etc., and effectively can stop the loss of effective ingredient in medical material, improving firing temperature can make the heat-resisting quantity of marmite improve, can more be uniformly dissolved from making medicinal ingredient, intense fire heated and boiled, slow fire boiling is extracted, decoct 2-3 hour, again add the pure water of 6 ~ 8 times amount, intense fire heated and boiled, slow fire boiling is extracted, decoct 1 ~ 2 hour, merge the extracting solution of twice,
Step 5: take fresh Herba Thysanolaenae maximae by described components by weight percent, bitter mustard, Herba Oberoniae iridifoliae, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle smash to pieces, and the mass concentration adding 5 times amount is 75% alcoholic solution, blender is used to stir 30min, the supernatant is extracted after leaving standstill 12h, carry out 85 ~ 95 DEG C of microwave sterilizating, sterilization time 90 ~ 120s, reclaims the ethanol in filtrate and concentrates, obtained mixture extractum;
Step 6: the mixture extractum mix homogeneously that extracting solution step 4 obtained and step 5 obtain, 3h is left standstill after stirring, then centrifuge 5000 ~ 6000r/min centrifugal sediment is used, filter, add Radix Oenotherae erythrosepalae extract, citron extract, the Ampelopsis grossedentata extrat of described components by weight percent more respectively, the Chinese medicine composition of the essential hypertension that namely obtains medical treatment;
Step 7: add lactose 6.8 parts, micropowder silica gel 5.2 parts, polyoxyethylene sorbitan monoleate 4.6 parts by following components by weight percent in the Chinese medicine composition that step 6 is obtained, capsule is made by corresponding Technology, described lactose Main Function is absorption dispersant, described micropowder silica gel Main Function is raising agent, and described polyoxyethylene sorbitan monoleate Main Function is wetting agent.
The pharmacologically active of each raw material of Chinese medicine of the present invention is as follows:
Pueraria lobota Bud root: dampness removing jaundice eliminating, promoting blood circulation to remove obstruction in the collateral, removing toxic substances and promoting subsidence of swelling, main icterohepatitis, rheumatic arthralgia, traumatic injury, carbuncle;
Medicine root of Herba Apii graveolentis: promoting blood circulation to remove obstruction in the collateral, removing toxic substances, main impairment caused by overstrain, sore;
Botrychium japonicum (Prantl) underw: liver heat removing and eyesight improving, detumescence of reducing phlegm, main conjunctival congestion and swelling pain, infantile hyperpyrexia is twitched, cough, spits blood, scrofula, carbuncle skin ulcer;
Radix Rubi Setchuenensis: removing heat from blood, invigorates blood circulation, and controls over-strained hemoptysis, hemoptysis, menoxenia, dysentery, scrofula, fracture;
Herba Thysanolaenae maximae: heat-clearing and toxic substances removing, promoting the production of body fluid to quench thirst, cures mainly malaria;
Bitter mustard: clearing away heat and cooling blood, diuresis removing food stagnancy, main high heat, dysuria, stops in stagnant, abdominal distention;
Radix broussonetiae: heat clearing away, removing heat from blood, dampness removing, eliminates the phlegm, and controls cough and spits blood, edema, metrorrhagia, traumatic injury;
Bai Guimu root: expelling wind and removing dampness, promoting blood circulation to remove obstruction in the collateral, main air pain of dampness syndrome, headache, paturient's hypogalactia;
Herba Oberoniae iridifoliae: regulate the flow of vital energy and help digestion, clearing away heat and promoting diuresis, cough-relieving pain relieving, for dyspepsia, stomachache, enteritis, urinary tract infection, cough, bronchitis, asthma, traumatic injury, fracture, venom;
Semen piptanthi concoloris: liver heat removing and eyesight improving, diuretic, intestine moistening, controls headache due to pathogenic wind-heat, acute conjunctivitis, hypertension, chronic constipation;
Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle: clear away heart-fire relieving restlessness, relieves heat and thirst;
Fructus Phyllanthi: clearing away heat and cooling blood, promoting digestion and invigorating the stomach, cough-relieving of promoting the production of body fluid.For heat in blood blood stasis, dyspepsia, abdominal distention, cough, laryngalgia, xerostomia;
Radix Oenotherae erythrosepalae oil: promoting blood circulation to remove obstruction in the collateral, endogenous wind stopping suppressing the hyperactive liver, detumescence sore, main obstruction of qi in the chest and cardialgia, apoplectic hemiplegia, stirring-up of pathogenic wind in the interior resulting from deficiency, children's moves more, wind dampness rheumatic anesthesia pain, and stomachache is had loose bowels, dysmenorrhea, oral-anal-genital ulcer syndrome, skin infection, eczema;
Citron extract: preventing phlegm from forming and stopping coughing, stomach invigorating of promoting the production of body fluid, for bronchitis, pertussis, inappetence, Vitamin C deficiency disease, heatstroke excessive thirst;
Ampelopsis grossedentata extrat: clearing away heat-damp and promoting diuresis, suppressing the hyperactive liver blood pressure lowering, promoting blood circulation to remove obstruction in the collateral, main dysentery, has loose bowels, and urine leaching pain, hypertension, dizzy order is swollen, traumatic injury.
Compared with prior art, beneficial effect of the present invention is embodied in: by selected multiple Chinese herbal medicine and Chinese herbal medicine extract, effectively can play clearing away heat and cooling blood, promoting the production of body fluid to quench thirst, removing toxic substances and promoting subsidence of swelling, liver heat removing and eyesight improving, effect of hemostasis blood pressure lowering, can also toxin expelling, stress of releiving, promote that body diet is normal, clear cigarette relieves the effect of alcohol, evident in efficacy, and drug effect is gentle, have no side effect, for treatment essential hypertension evident in efficacy, short treating period, instant effect, easy to use, through clinical verification without any toxic and side effects, the relieved use of this patient.
Detailed description of the invention
Below in conjunction with detailed description of the invention, the present invention is described in more detail:
Embodiment 1: a kind of Chinese medicine composition for the treatment of essential hypertension, component meter by weight, is mainly made up of following raw material: Pueraria lobota Bud root 60 parts, medicine root of Herba Apii graveolentis 55 parts, Botrychium japonicum (Prantl) underw 52 parts, Radix Rubi Setchuenensis 42 parts, Herba Thysanolaenae maximae 40 parts, 38 parts, bitter mustard, Radix broussonetiae 38 parts, Bai Guimu root 35 parts, Herba Oberoniae iridifoliae 36 parts, Semen piptanthi concoloris 34 parts, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle 30 parts, Fructus Phyllanthi 30 parts, Radix Oenotherae erythrosepalae extract 4.2 parts, citron extract 3.8 parts, Ampelopsis grossedentata extrat 2.8 parts.
The preparation method that a kind of Chinese medicine composition for the treatment of essential hypertension makes capsule comprises the following steps:
Step one: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 100 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, described mixed enzyme is by chitinase, cellulase, papain is fully uniformly mixed according to the weight ratio of 4:1:2 and obtains, it is respectively to cellulose in Radix Oenotherae erythrosepalae and the mixed solution of water, starch, the organic substances such as protein carry out enzymolysis, thus isolate active substance containing Radix Oenotherae erythrosepalae oil enzymolysis 2h under the condition of vacuum-0.03MPa and temperature 50 C fast, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 80 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained, contain in Radix Oenotherae erythrosepalae oil: r-linoleic acid, magnesium, zinc, copper, vitamin C, E, B6, the effective ingredient such as B5, it is the extremely polynary undersaturated essential fatty acid of one, the endogenous factor of inflammatory that Oleum Arachidis hypogaeae semen tetraenoic acid produces in vivo can be replaced in the process of metabolism in vivo, as prostaglandin, the Prothrombin of leukotrienes and initiation Coagulation test, except anti-inflammatory effect, Radix Oenotherae erythrosepalae oil also has reduction Coagulation test, the effect of antithrombotic,
Step 2: cleaned by lemon fruit, is ground into 20 orders with pulverizer, carries out supersound extraction with ethanol, and solid-liquid ratio is 1:6, the mass concentration of ethanol is 60%, and ultrasonic power is 30KHz, and temperature is 55 DEG C, and extraction time is 30 minutes, be separated with macroporous adsorption resin chromatography, dry, the brown color fine powder obtained is citron extract again, citron extract has and promotes the production of body fluid, and quenches the thirst, drives away summer heat, antiabortive, pharyngalgia xerostomia, gastral cavilty flatulence, hypertension, myocardial infarction, effect of anorexia;
Step 3: by Ampelopsis grossedentata crushed after being dried, cross 20 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is filter after 3,85 DEG C of heating 30min leave standstill, and obtains Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, is cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtains Ampelopsis grossedentata extrat;
Step 4: take Pueraria lobota Bud root by described components by weight percent, medicine root of Herba Apii graveolentis, Botrychium japonicum (Prantl) underw, Radix Rubi Setchuenensis, Radix broussonetiae, Bai Guimu root, Fructus Phyllanthi, all medical materials are cut into the thin slice of 2mm, be placed in oven for drying, baking oven set temperature 60 DEG C, make Chinese medicine tablet moisture lower than 5%, take the Semen piptanthi concoloris seed of described components by weight percent, crushed after being dried, cross 50 mesh sieves, obtain Semen piptanthi concoloris coarse powder, by Chinese medicine tablet and the mixing of Semen piptanthi concoloris coarse powder, add the pure water of 8 times amount of mixing medical material gross weight, soak 8h, use special marmite, fine coal ash quantity after described special marmite refers to the calcining added in clay is 1.2 times that common marmite is fired, firing temperature is higher than common marmite 100 DEG C, the raising of fine coal ash quantity can increase the activated carbon constituents in marmite, thus a large amount of negative oxygen ion can be formed make to have strong physical absorption and chemical adsorption capacity, therefore can except the heavy metal ion in anhydrating, stink, rust etc., and effectively can stop the loss of effective ingredient in medical material, improving firing temperature can make the heat-resisting quantity of marmite improve, can more be uniformly dissolved from making medicinal ingredient, intense fire heated and boiled, slow fire boiling is extracted, decoct 2 hours, again add the pure water of 6 times amount, intense fire heated and boiled, slow fire boiling is extracted, decoct 1 hour, merge the extracting solution of twice,
Step 5: take fresh Herba Thysanolaenae maximae by described components by weight percent, bitter mustard, Herba Oberoniae iridifoliae, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle smash to pieces, and the mass concentration adding 5 times amount is 75% alcoholic solution, blender is used to stir 30min, the supernatant is extracted after leaving standstill 12h, carry out 85 DEG C of microwave sterilizating, sterilization time 90s, reclaims the ethanol in filtrate and concentrates, obtained mixture extractum;
Step 6: the mixture extractum mix homogeneously that extracting solution step 4 obtained and step 5 obtain, 3h is left standstill after stirring, then centrifuge 5000r/min centrifugal sediment is used, filter, add Radix Oenotherae erythrosepalae extract, citron extract, the Ampelopsis grossedentata extrat of described components by weight percent more respectively, the Chinese medicine composition of the essential hypertension that namely obtains medical treatment;
Step 7: add lactose 6.8 parts, micropowder silica gel 5.2 parts, polyoxyethylene sorbitan monoleate 4.6 parts by following components by weight percent in the Chinese medicine composition that step 6 is obtained, capsule is made by corresponding Technology, described lactose Main Function is absorption dispersant, described micropowder silica gel Main Function is raising agent, and described polyoxyethylene sorbitan monoleate Main Function is wetting agent.
Embodiment 2: a kind of Chinese medicine composition for the treatment of essential hypertension, component meter by weight, is mainly made up of following raw material: Pueraria lobota Bud root 75 parts, medicine root of Herba Apii graveolentis 68 parts, Botrychium japonicum (Prantl) underw 65 parts, Radix Rubi Setchuenensis 54 parts, Herba Thysanolaenae maximae 49 parts, 47 parts, bitter mustard, Radix broussonetiae 46 parts, Bai Guimu root 44 parts, Herba Oberoniae iridifoliae 42 parts, Semen piptanthi concoloris 40 parts, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle 38 parts, Fructus Phyllanthi 37 parts, Radix Oenotherae erythrosepalae extract 4.9 parts, citron extract 4.6 parts, Ampelopsis grossedentata extrat 3.7 parts.
The preparation method that a kind of Chinese medicine composition for the treatment of essential hypertension makes capsule comprises the following steps:
Step one: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 110 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, described mixed enzyme is by chitinase, cellulase, papain is fully uniformly mixed according to the weight ratio of 4:1:2 and obtains, it is respectively to cellulose in Radix Oenotherae erythrosepalae and the mixed solution of water, starch, the organic substances such as protein carry out enzymolysis, thus isolate active substance containing Radix Oenotherae erythrosepalae oil enzymolysis 3.5h under the condition of vacuum-0.04MPa and temperature 55 DEG C fast, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 85 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained, contain in Radix Oenotherae erythrosepalae oil: r-linoleic acid, magnesium, zinc, copper, vitamin C, E, B6, the effective ingredient such as B5, it is the extremely polynary undersaturated essential fatty acid of one, the endogenous factor of inflammatory that Oleum Arachidis hypogaeae semen tetraenoic acid produces in vivo can be replaced in the process of metabolism in vivo, as prostaglandin, the Prothrombin of leukotrienes and initiation Coagulation test, except anti-inflammatory effect, Radix Oenotherae erythrosepalae oil also has reduction Coagulation test, the effect of antithrombotic,
Step 2: cleaned by lemon fruit, is ground into 30 orders with pulverizer, carries out supersound extraction with ethanol, and solid-liquid ratio is 1:4, the mass concentration of ethanol is 70%, and ultrasonic power is 35KHz, and temperature is 55 DEG C, and extraction time is 30 minutes, be separated with macroporous adsorption resin chromatography, dry, the brown color fine powder obtained is citron extract again, citron extract has and promotes the production of body fluid, and quenches the thirst, drives away summer heat, antiabortive, pharyngalgia xerostomia, gastral cavilty flatulence, hypertension, myocardial infarction, effect of anorexia;
Step 3: by Ampelopsis grossedentata crushed after being dried, cross 25 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is filter after 3,85 DEG C of heating 30min leave standstill, and obtains Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, is cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtains Ampelopsis grossedentata extrat;
Step 4: take Pueraria lobota Bud root by described components by weight percent, medicine root of Herba Apii graveolentis, Botrychium japonicum (Prantl) underw, Radix Rubi Setchuenensis, Radix broussonetiae, Bai Guimu root, Fructus Phyllanthi, all medical materials are cut into the thin slice of 2mm, be placed in oven for drying, baking oven set temperature 60 DEG C, make Chinese medicine tablet moisture lower than 5%, take the Semen piptanthi concoloris seed of described components by weight percent, crushed after being dried, cross 50 mesh sieves, obtain Semen piptanthi concoloris coarse powder, by Chinese medicine tablet and the mixing of Semen piptanthi concoloris coarse powder, add the pure water of 9 times amount of mixing medical material gross weight, soak 10h, use special marmite, fine coal ash quantity after described special marmite refers to the calcining added in clay is 1.2 times that common marmite is fired, firing temperature is higher than common marmite 100 DEG C, the raising of fine coal ash quantity can increase the activated carbon constituents in marmite, thus a large amount of negative oxygen ion can be formed make to have strong physical absorption and chemical adsorption capacity, therefore can except the heavy metal ion in anhydrating, stink, rust etc., and effectively can stop the loss of effective ingredient in medical material, improving firing temperature can make the heat-resisting quantity of marmite improve, can more be uniformly dissolved from making medicinal ingredient, intense fire heated and boiled, slow fire boiling is extracted, decoct 2.5 hours, again add the pure water of 7 times amount, intense fire heated and boiled, slow fire boiling is extracted, decoct 1.5 hours, merge the extracting solution of twice,
Step 5: take fresh Herba Thysanolaenae maximae by described components by weight percent, bitter mustard, Herba Oberoniae iridifoliae, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle smash to pieces, and the mass concentration adding 5 times amount is 75% alcoholic solution, blender is used to stir 30min, the supernatant is extracted after leaving standstill 12h, carry out 90 DEG C of microwave sterilizating, sterilization time 105s, reclaims the ethanol in filtrate and concentrates, obtained mixture extractum;
Step 6: the mixture extractum mix homogeneously that extracting solution step 4 obtained and step 5 obtain, 3h is left standstill after stirring, then centrifuge 5500r/min centrifugal sediment is used, filter, add Radix Oenotherae erythrosepalae extract, citron extract, the Ampelopsis grossedentata extrat of described components by weight percent more respectively, the Chinese medicine composition of the essential hypertension that namely obtains medical treatment;
Step 7: add lactose 6.8 parts, micropowder silica gel 5.2 parts, polyoxyethylene sorbitan monoleate 4.6 parts by following components by weight percent in the Chinese medicine composition that step 6 is obtained, capsule is made by corresponding Technology, described lactose Main Function is absorption dispersant, described micropowder silica gel Main Function is raising agent, and described polyoxyethylene sorbitan monoleate Main Function is wetting agent.
Embodiment 3: a kind of Chinese medicine composition for the treatment of essential hypertension, component meter by weight, is mainly made up of following raw material: Pueraria lobota Bud root 90 parts, medicine root of Herba Apii graveolentis 80 parts, Botrychium japonicum (Prantl) underw 78 parts, Radix Rubi Setchuenensis 65 parts, Herba Thysanolaenae maximae 58 parts, 56 parts, bitter mustard, Radix broussonetiae 55 parts, Bai Guimu root 52 parts, Herba Oberoniae iridifoliae 48 parts, Semen piptanthi concoloris 46 parts, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle 45 parts, Fructus Phyllanthi 43 parts, Radix Oenotherae erythrosepalae extract 5.6 parts, citron extract 5.4 parts, Ampelopsis grossedentata extrat 4.6 parts.
The preparation method that a kind of Chinese medicine composition for the treatment of essential hypertension makes capsule comprises the following steps:
Step one: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 120 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, described mixed enzyme is by chitinase, cellulase, papain is fully uniformly mixed according to the weight ratio of 4:1:2 and obtains, it is respectively to cellulose in Radix Oenotherae erythrosepalae and the mixed solution of water, starch, the organic substances such as protein carry out enzymolysis, thus isolate active substance containing Radix Oenotherae erythrosepalae oil enzymolysis 5h under the condition of vacuum-0.05MPa and temperature 60 C fast, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 90 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained, contain in Radix Oenotherae erythrosepalae oil: r-linoleic acid, magnesium, zinc, copper, vitamin C, E, B6, the effective ingredient such as B5, it is the extremely polynary undersaturated essential fatty acid of one, the endogenous factor of inflammatory that Oleum Arachidis hypogaeae semen tetraenoic acid produces in vivo can be replaced in the process of metabolism in vivo, as prostaglandin, the Prothrombin of leukotrienes and initiation Coagulation test, except anti-inflammatory effect, Radix Oenotherae erythrosepalae oil also has reduction Coagulation test, the effect of antithrombotic,
Step 2: cleaned by lemon fruit, is ground into 40 orders with pulverizer, carries out supersound extraction with ethanol, and solid-liquid ratio is 1:2, the mass concentration of ethanol is 80%, and ultrasonic power is 40KHz, and temperature is 55 DEG C, and extraction time is 30 minutes, be separated with macroporous adsorption resin chromatography, dry, the brown color fine powder obtained is citron extract again, citron extract has and promotes the production of body fluid, and quenches the thirst, drives away summer heat, antiabortive, pharyngalgia xerostomia, gastral cavilty flatulence, hypertension, myocardial infarction, effect of anorexia;
Step 3: by Ampelopsis grossedentata crushed after being dried, cross 30 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is filter after 3,85 DEG C of heating 30min leave standstill, and obtains Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, is cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtains Ampelopsis grossedentata extrat;
Step 4: take Pueraria lobota Bud root by described components by weight percent, medicine root of Herba Apii graveolentis, Botrychium japonicum (Prantl) underw, Radix Rubi Setchuenensis, Radix broussonetiae, Bai Guimu root, Fructus Phyllanthi, all medical materials are cut into the thin slice of 2mm, be placed in oven for drying, baking oven set temperature 60 DEG C, make Chinese medicine tablet moisture lower than 5%, take the Semen piptanthi concoloris seed of described components by weight percent, crushed after being dried, cross 50 mesh sieves, obtain Semen piptanthi concoloris coarse powder, by Chinese medicine tablet and the mixing of Semen piptanthi concoloris coarse powder, add the pure water of 10 times amount of mixing medical material gross weight, soak 12h, use special marmite, fine coal ash quantity after described special marmite refers to the calcining added in clay is 1.2 times that common marmite is fired, firing temperature is higher than common marmite 100 DEG C, the raising of fine coal ash quantity can increase the activated carbon constituents in marmite, thus a large amount of negative oxygen ion can be formed make to have strong physical absorption and chemical adsorption capacity, therefore can except the heavy metal ion in anhydrating, stink, rust etc., and effectively can stop the loss of effective ingredient in medical material, improving firing temperature can make the heat-resisting quantity of marmite improve, can more be uniformly dissolved from making medicinal ingredient, intense fire heated and boiled, slow fire boiling is extracted, decoct 3 hours, again add the pure water of 8 times amount, intense fire heated and boiled, slow fire boiling is extracted, decoct 2 hours, merge the extracting solution of twice,
Step 5: take fresh Herba Thysanolaenae maximae by described components by weight percent, bitter mustard, Herba Oberoniae iridifoliae, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle smash to pieces, and the mass concentration adding 5 times amount is 75% alcoholic solution, blender is used to stir 30min, the supernatant is extracted after leaving standstill 12h, carry out 95 DEG C of microwave sterilizating, sterilization time 120s, reclaims the ethanol in filtrate and concentrates, obtained mixture extractum;
Step 6: the mixture extractum mix homogeneously that extracting solution step 4 obtained and step 5 obtain, 3h is left standstill after stirring, then centrifuge 6000r/min centrifugal sediment is used, filter, add Radix Oenotherae erythrosepalae extract, citron extract, the Ampelopsis grossedentata extrat of described components by weight percent more respectively, the Chinese medicine composition of the essential hypertension that namely obtains medical treatment;
Step 7: add lactose 6.8 parts, micropowder silica gel 5.2 parts, polyoxyethylene sorbitan monoleate 4.6 parts by following components by weight percent in the Chinese medicine composition that step 6 is obtained, capsule is made by corresponding Technology, described lactose Main Function is absorption dispersant, described micropowder silica gel Main Function is raising agent, and described polyoxyethylene sorbitan monoleate Main Function is wetting agent.
Clinical trial:
1. clinical case is selected and is divided into groups: inventor collects 120 routine primary hypertension patients altogether, is divided into four groups at random, often organizes 30 people, three groups of test group, one group of matched group, and the data such as four groups of sexes, age, state of an illness there are no significant difference, has comparability.
2. test method: take the Chinese medicinal composition capsules of embodiment 1, embodiment 2, embodiment 3 preparation to respectively test group patient, matched group takes common depressor, takes 2 every day, 10 days is a course for the treatment of, and experimental period is three courses for the treatment of.
3. criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
(1) fully recover: blood pressure recover normal condition, withdrawal after three months blood pressure normal;
(2) effective: blood pressure reduces, but does not reach normal condition, and after withdrawal, blood pressure does not raise;
(3) invalid: blood pressure is without obviously changing or raising.
3.2 treatment statistical results
Table 1-tetra-group comparitive study
The medicine taken | Case number | Recovery from illness | Effective | Invalid | Untoward reaction | Total effective rate % |
Embodiment 1 | 30 | 12 | 13 | 5 | 0 | 83.3 |
Embodiment 2 | 30 | 16 | 13 | 1 | 0 | 96.6 |
Embodiment 3 | 30 | 13 | 14 | 3 | 0 | 90.0 |
Common depressor | 30 | 3 | 16 | 9 | 2 | 63.3 |
4. conclusion: in clinical trial process, the patient accepting Drug therapy of the present invention finds no any untoward reaction, as seen from the data in Table 1, the hypertensive total effective rate of drugs in idiopathic of the present invention reaches more than 83.3%, be the safe and effective medicine for the treatment of essential hypertension, there is good clinical meaning.
5. clinical individual case
Case 1: Huang, man, 32 years old, occurred before 3 months that intermittent blood pressure raises, develop into gradually and have a dizzy spell, the normal work of impact and life, take Western medicine and control blood pressure, medicine stops rear blood pressure and raises immediately, after the course for the treatment of of Chinese medicinal composition capsules agent of the treatment essential hypertension bringing into use the embodiment of the present invention 1 to prepare two months ago, blood pressure returns to normal range, withdrawal after three courses for the treatment of, withdrawal one month, has no bounce-back up till now.
Case 2: Korea Spro so-and-so, female, 48 years old, heritability primary hypertension patient, its grandfather, father, elder brother suffers from essential hypertension, long-term taking Western medicine controlled release agent, start to occur headache, after half course for the treatment of of Chinese medicinal composition capsules agent of the treatment essential hypertension using the embodiment of the present invention 2 to prepare, blood pressure returns to normal range, take medicine continuously three courses for the treatment of, after half a year, have no recurrence.
Case 3: section, man, 62 years old, primary hypertension patient, long-term alcohol smoking, decreased liver function, pulmonary's easy infection inflammation, intermittent blood pressure raises and causes having a dizzy spell, and cannot normally walk, long-term taking Western medicine slow releasing agent, along with the age increases, slow releasing function worse and worse, after the course for the treatment of of Chinese medicinal composition capsules agent of the treatment essential hypertension using the embodiment of the present invention 3 to prepare, blood pressure starts to reduce, soft tissue swelling alleviates, and after two courses for the treatment of, blood pressure returns to normal range, take 5 courses for the treatment of continuously, drug withdrawal has no recurrence half a year.
Last it is noted that above embodiment is only in order to illustrate technical scheme of the present invention, be not intended to limit; Although with reference to previous embodiment to invention has been detailed description, those of ordinary skill in the art is to be understood that: it still can be modified to the technical scheme described in previous embodiment, or carries out equivalent replacement to wherein portion of techniques feature; And these amendments or replacement, do not make the essence of appropriate technical solution depart from the spirit and scope of embodiment of the present invention technical scheme.
Claims (10)
1. treat the Chinese medicine composition of essential hypertension for one kind, it is characterized in that, component meter by weight, mainly be made up of following raw material: Pueraria lobota Bud root 60 ~ 90 parts, medicine root of Herba Apii graveolentis 55 ~ 80 parts, Botrychium japonicum (Prantl) underw 52 ~ 78 parts, Radix Rubi Setchuenensis 42 ~ 65 parts, Herba Thysanolaenae maximae 40 ~ 58 parts, bitter 38 ~ 56 parts, mustard, Radix broussonetiae 38 ~ 55 parts, Bai Guimu root 35 ~ 52 parts, Herba Oberoniae iridifoliae 36 ~ 48 parts, Semen piptanthi concoloris 34 ~ 46 parts, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle 30 ~ 45 parts, Fructus Phyllanthi 30 ~ 43 parts, Radix Oenotherae erythrosepalae extract 4.2 ~ 5.6 parts, citron extract 3.8 ~ 5.4 parts, Ampelopsis grossedentata extrat 2.8 ~ 4.6 parts.
2. a kind of Chinese medicine composition for the treatment of essential hypertension as claimed in claim 1, it is characterized in that, component meter by weight, is mainly made up of following raw material: Pueraria lobota Bud root 75 parts, medicine root of Herba Apii graveolentis 68 parts, Botrychium japonicum (Prantl) underw 65 parts, Radix Rubi Setchuenensis 54 parts, Herba Thysanolaenae maximae 49 parts, 47 parts, bitter mustard, Radix broussonetiae 46 parts, Bai Guimu root 44 parts, Herba Oberoniae iridifoliae 42 parts, Semen piptanthi concoloris 40 parts, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle 38 parts, Fructus Phyllanthi 37 parts, Radix Oenotherae erythrosepalae extract 4.9 parts, citron extract 4.6 parts, Ampelopsis grossedentata extrat 3.7 parts.
3. a kind of Chinese medicine composition for the treatment of essential hypertension as described in claim 1 ~ 2 any one, it is characterized in that, described Radix Oenotherae erythrosepalae extract is Radix Oenotherae erythrosepalae oil, its extracting method is: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 100 ~ 120 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, enzymolysis 2 ~ 5h under the condition of vacuum-0.03 ~-0.05MPa and temperature 50 ~ 60 DEG C, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 80 ~ 90 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained.
4. a kind of Chinese medicine composition for the treatment of essential hypertension as claimed in claim 3, is characterized in that, described mixed enzyme to be fully uniformly mixed according to the weight ratio of 4:1:2 by chitinase, cellulase, papain to obtain.
5. a kind of Chinese medicine composition for the treatment of essential hypertension as described in claim 1 ~ 2 any one, it is characterized in that, described citron extract preparation method is: cleaned by lemon fruit, 20 ~ 40 orders are ground into pulverizer, supersound extraction is carried out with ethanol, solid-liquid ratio is 1:(2 ~ 6), the mass concentration of ethanol is 60 ~ 80%, ultrasonic power is 30 ~ 40KHz, temperature is 55 DEG C, and extraction time is 30 minutes, then is separated with macroporous adsorption resin chromatography, drying, the brown color fine powder obtained is citron extract.
6. a kind of Chinese medicine composition for the treatment of essential hypertension as described in claim 1 ~ 2 any one, it is characterized in that, described Ampelopsis grossedentata extrat preparation method is: by Ampelopsis grossedentata crushed after being dried, cross 20 ~ 30 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is 3, filter after 85 DEG C of heating 30min leave standstill, obtain Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, be cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtain Ampelopsis grossedentata extrat.
7. a kind of preparation method for the treatment of the Chinese medicine composition of essential hypertension as described in claim 1 ~ 6 any one, is characterized in that, comprise the following steps:
Step one: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 100 ~ 120 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, described mixed enzyme is by chitinase, cellulase, papain is fully uniformly mixed according to the weight ratio of 4:1:2 and obtains, enzymolysis 2 ~ 5h under the condition of vacuum-0.03 ~-0.05MPa and temperature 50 ~ 60 DEG C, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 80 ~ 90 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained,
Step 2: lemon fruit is cleaned, 20 ~ 40 orders are ground into pulverizer, carry out supersound extraction with ethanol, solid-liquid ratio is 1:(2 ~ 6), the mass concentration of ethanol is 60 ~ 80%, ultrasonic power is 30 ~ 40KHz, temperature is 55 DEG C, and extraction time is 30 minutes, then is separated with macroporous adsorption resin chromatography, drying, the brown color fine powder obtained is citron extract;
Step 3: by Ampelopsis grossedentata crushed after being dried, cross 20 ~ 30 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is filter after 3,85 DEG C of heating 30min leave standstill, and obtains Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, is cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtains Ampelopsis grossedentata extrat;
Step 4: take Pueraria lobota Bud root by described components by weight percent, medicine root of Herba Apii graveolentis, Botrychium japonicum (Prantl) underw, Radix Rubi Setchuenensis, Radix broussonetiae, Bai Guimu root, Fructus Phyllanthi, all medical materials are cut into the thin slice of 2mm, be placed in oven for drying, baking oven set temperature 60 DEG C, make Chinese medicine tablet moisture lower than 5%, take the Semen piptanthi concoloris seed of described components by weight percent, crushed after being dried, cross 50 mesh sieves, obtain Semen piptanthi concoloris coarse powder, by Chinese medicine tablet and the mixing of Semen piptanthi concoloris coarse powder, add the pure water of 8 ~ 10 times amount of mixing medical material gross weight, soak 8 ~ 12h, use special marmite, intense fire heated and boiled, slow fire boiling is extracted, decoct 2-3 hour, again add the pure water of 6 ~ 8 times amount, intense fire heated and boiled, slow fire boiling is extracted, decoct 1 ~ 2 hour, merge the extracting solution of twice,
Step 5: take fresh Herba Thysanolaenae maximae by described components by weight percent, bitter mustard, Herba Oberoniae iridifoliae, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle smash to pieces, and the mass concentration adding 5 times amount is 75% alcoholic solution, blender is used to stir 30min, the supernatant is extracted after leaving standstill 12h, carry out 85 ~ 95 DEG C of microwave sterilizating, sterilization time 90 ~ 120s, reclaims the ethanol in filtrate and concentrates, obtained mixture extractum;
Step 6: the mixture extractum mix homogeneously that extracting solution step 4 obtained and step 5 obtain, 3h is left standstill after stirring, then centrifuge 5000 ~ 6000r/min centrifugal sediment is used, filter, add Radix Oenotherae erythrosepalae extract, citron extract, the Ampelopsis grossedentata extrat of described components by weight percent more respectively, the Chinese medicine composition of the essential hypertension that namely obtains medical treatment.
8. a kind of preparation method for the treatment of the Chinese medicine composition of essential hypertension as claimed in claim 7, is characterized in that described Chinese medicine composition to make capsule.
9. a kind of preparation method for the treatment of the Chinese medicine composition of essential hypertension as claimed in claim 8, is characterized in that the preparation method of described capsule comprises the following steps:
Step one: after evening primrose seed wash clean, be placed in oven drying, baking oven set temperature 60 DEG C, make its moisture lower than 5%, then ultra micro comminution by gas stream is carried out, cross 100 ~ 120 mesh sieves, obtain evening primrose seed powder, add the distilled water of 10 times amount, add 0.08 times amount mixed enzyme again, described mixed enzyme is by chitinase, cellulase, papain is fully uniformly mixed according to the weight ratio of 4:1:2 and obtains, enzymolysis 2 ~ 5h under the condition of vacuum-0.03 ~-0.05MPa and temperature 50 ~ 60 DEG C, by the enzymolysis solution microwave radiation exaraction 45min under the condition of temperature 80 ~ 90 DEG C obtained, with Rotary Evaporators concentrating under reduced pressure, organic solvent is removed, namely Radix Oenotherae erythrosepalae oil is obtained,
Step 2: lemon fruit is cleaned, 20 ~ 40 orders are ground into pulverizer, carry out supersound extraction with ethanol, solid-liquid ratio is 1:(2 ~ 6), the mass concentration of ethanol is 60 ~ 80%, ultrasonic power is 30 ~ 40KHz, temperature is 55 DEG C, and extraction time is 30 minutes, then is separated with macroporous adsorption resin chromatography, drying, the brown color fine powder obtained is citron extract;
Step 3: by Ampelopsis grossedentata crushed after being dried, cross 20 ~ 30 mesh sieves, obtain Ampelopsis grossedentata coarse powder, to add in Ampelopsis grossedentata coarse powder 15 times of quality containing the protectant aqueous solution of flavone, in aqueous solution, the protectant mass percent of flavone is 0.05%, the pH value of aqueous solution is filter after 3,85 DEG C of heating 30min leave standstill, and obtains Ampelopsis grossedentata water clear liquid, Ampelopsis grossedentata Aqueous extracts clear liquid is heated, vacuum concentration, is cooled to 5 DEG C, crystallization, to the deionized water drip washing adding 5 times of quality in crystal, centrifuge dehydration, microwave drying, obtains Ampelopsis grossedentata extrat;
Step 4: take Pueraria lobota Bud root by described components by weight percent, medicine root of Herba Apii graveolentis, Botrychium japonicum (Prantl) underw, Radix Rubi Setchuenensis, Radix broussonetiae, Bai Guimu root, Fructus Phyllanthi, all medical materials are cut into the thin slice of 2mm, be placed in oven for drying, baking oven set temperature 60 DEG C, make Chinese medicine tablet moisture lower than 5%, take the Semen piptanthi concoloris seed of described components by weight percent, crushed after being dried, cross 50 mesh sieves, obtain Semen piptanthi concoloris coarse powder, by Chinese medicine tablet and the mixing of Semen piptanthi concoloris coarse powder, add the pure water of 8 ~ 10 times amount of mixing medical material gross weight, soak 8 ~ 12h, use special marmite, intense fire heated and boiled, slow fire boiling is extracted, decoct 2-3 hour, again add the pure water of 6 ~ 8 times amount, intense fire heated and boiled, slow fire boiling is extracted, decoct 1 ~ 2 hour, merge the extracting solution of twice,
Step 5: take fresh Herba Thysanolaenae maximae by described components by weight percent, bitter mustard, Herba Oberoniae iridifoliae, Phyllostachys nigra (Lodd.) Munrovar.henonis(Mitf.) Stapfex Rendle smash to pieces, and the mass concentration adding 5 times amount is 75% alcoholic solution, blender is used to stir 30min, the supernatant is extracted after leaving standstill 12h, carry out 85 ~ 95 DEG C of microwave sterilizating, sterilization time 90 ~ 120s, reclaims the ethanol in filtrate and concentrates, obtained mixture extractum;
Step 6: the mixture extractum mix homogeneously that extracting solution step 4 obtained and step 5 obtain, 3h is left standstill after stirring, then centrifuge 5000 ~ 6000r/min centrifugal sediment is used, filter, add Radix Oenotherae erythrosepalae extract, citron extract, the Ampelopsis grossedentata extrat of described components by weight percent more respectively, the Chinese medicine composition of the essential hypertension that namely obtains medical treatment;
Step 7: add lactose 6.8 parts, micropowder silica gel 5.2 parts, polyoxyethylene sorbitan monoleate 4.6 parts in the Chinese medicine composition that step 6 is obtained by following components by weight percent, make capsule by corresponding Technology.
10. a kind of preparation method for the treatment of the Chinese medicine composition of essential hypertension as described in claim 7 or 9 any one, it is characterized in that described special marmite refer to the calcining added in clay after fine coal ash quantity be 1.2 times that common marmite is fired, firing temperature is higher than common marmite 100 DEG C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510956534.6A CN105362785A (en) | 2015-12-17 | 2015-12-17 | Medicine composition for treating primary hypertension and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510956534.6A CN105362785A (en) | 2015-12-17 | 2015-12-17 | Medicine composition for treating primary hypertension and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105362785A true CN105362785A (en) | 2016-03-02 |
Family
ID=55365735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510956534.6A Pending CN105362785A (en) | 2015-12-17 | 2015-12-17 | Medicine composition for treating primary hypertension and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105362785A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535170A (en) * | 2016-01-25 | 2016-05-04 | 李秀华 | Compound male private part nursing lotion and preparation method thereof |
CN107397843A (en) * | 2016-05-19 | 2017-11-28 | 苏州凯祥生物科技有限公司 | Application of the Ampelopsis grossedentata extrat in farnesoid X receptor activator is prepared |
CN110089548A (en) * | 2019-06-12 | 2019-08-06 | 广西壮族自治区水产科学研究院 | A kind of undamaged online preservation method of prawn |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61197524A (en) * | 1985-02-15 | 1986-09-01 | Gunze Ltd | Remedy for hypertension |
CN1428171A (en) * | 2002-12-20 | 2003-07-09 | 张晴龙 | Chinese medicine for curing primary hypertension and its preparation method |
CN104522217A (en) * | 2015-01-22 | 2015-04-22 | 重庆中宝生物制药有限公司 | Vine tea extract and applications thereof |
-
2015
- 2015-12-17 CN CN201510956534.6A patent/CN105362785A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61197524A (en) * | 1985-02-15 | 1986-09-01 | Gunze Ltd | Remedy for hypertension |
CN1428171A (en) * | 2002-12-20 | 2003-07-09 | 张晴龙 | Chinese medicine for curing primary hypertension and its preparation method |
CN104522217A (en) * | 2015-01-22 | 2015-04-22 | 重庆中宝生物制药有限公司 | Vine tea extract and applications thereof |
Non-Patent Citations (2)
Title |
---|
犀文图书: "《血压高了怎么吃》", 30 April 2015, 浙江科学技术出版社 * |
王绪前: "《小病不用慌 厨房里面有偏方》", 30 April 2014, 中国医药科技出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535170A (en) * | 2016-01-25 | 2016-05-04 | 李秀华 | Compound male private part nursing lotion and preparation method thereof |
CN107397843A (en) * | 2016-05-19 | 2017-11-28 | 苏州凯祥生物科技有限公司 | Application of the Ampelopsis grossedentata extrat in farnesoid X receptor activator is prepared |
CN107397843B (en) * | 2016-05-19 | 2021-03-02 | 苏州凯祥生物科技有限公司 | Application of vine tea extract in preparation of farnesol X receptor agonist |
CN110089548A (en) * | 2019-06-12 | 2019-08-06 | 广西壮族自治区水产科学研究院 | A kind of undamaged online preservation method of prawn |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104172159A (en) | Composition with auxiliary protection effect on alcoholic liver injury and preparation method thereof | |
CN108391774A (en) | A kind of drinks of antigout and preparation method thereof | |
CN105362785A (en) | Medicine composition for treating primary hypertension and preparation method thereof | |
CN102343050B (en) | Eye ointment for treating eye diseases | |
CN112515014A (en) | Kudzuvine root polysaccharide sweet zong black tea and preparation method thereof | |
CN103083429B (en) | Blood fat-reducing traditional Chinese medicine formula | |
CN102293796B (en) | Effective parts of the wind-chasing umbrella and its extraction method and application | |
CN111437353A (en) | Medicinal and edible plant composition for assisting in reducing blood sugar and application thereof | |
CN104666564A (en) | Schisandra chinensis-oyster dealcoholic liver-protecting health medicine and preparation method thereof | |
CN116138455A (en) | Panax notoginseng polysaccharide extract and its application in the preparation of anti-fatigue products | |
CN104548032A (en) | Traditional Chinese medicine composition with cough-relieving curative effect | |
CN103340991B (en) | Oral liquid for nursing diabetics and preparation method thereof | |
CN103417911A (en) | Traditional Chinese medicine composition for supporting chemo-treatment | |
CN106822684A (en) | Prevent and treat Chinese medicine composition, medicine of hyperuricemia and its preparation method and application | |
CN113875864A (en) | Blood sugar reducing and inhibiting tea and preparation method thereof | |
CN112971138A (en) | Health food for treating gout and preparation method thereof | |
CN111700927A (en) | A kind of medicine and food homologous composition with hypoglycemic effect and its preparation method and application | |
CN118649442B (en) | Traditional Chinese medicine composition for reducing uric acid obtained through liquid-liquid extraction | |
CN110694002A (en) | Blood circulation activating and turbidity removing momordica grosvenori tea composition and preparation method thereof | |
CN103461576B (en) | A health-care tea for clearing away heat and lowering blood pressure | |
CN114931214B (en) | Chinese herbal medicine composition for improving hearing impairment and preparation method and application thereof | |
CN103860942A (en) | Drug for treating phlegm turbidity nasopharynx cancer and preparation method thereof | |
CN103690771B (en) | Be used for the treatment of medicine of lamb colibacillosis and preparation method thereof | |
CN103417669B (en) | Drug for treatment of abdominal pain and diarrhea | |
CN102188681B (en) | Traditional Chinese drug composition for treating pelvic inflammatory disease, preparation method, application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160302 |